comparemela.com

Latest Breaking News On - Whole fundamental - Page 1 : comparemela.com

Collegium Pharmaceutical, Inc Announces Redemption of Outstanding 2 625% Convertible Senior Notes Due 2026

STOUGHTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified speci.

United statesNew yorkMarissa samuelsChristopher jamesCollegium pharmaceutical incYork mellon trust companyExchange commissionCorporate communicationsCompany annual reports on formConvertible senior notes dueRedemption dateRedemption priceNew york mellon trust companyDepository trust companyNew york cityConversion agent

Ascendis Pharma A/S : Form 6-K -March 27, 2024 at 04:09 pm EDT

Ascendis Pharma A/S Name, Registered Office and Objects of the Company: Article 1 .

United statesDistrict of columbiaCayman islandsMenlo parkUnited kingdomPalo altoNew yorkRepublic of irelandKingdom of denmarkJoshua hahn ascendis pharmaAscendis pharma adssAscendis pharmaJohnc williamsAscendis pharmasMarkv roederNo sinking fund

Ascendis Pharma A/S : Form 6-K -January 02, 2024 at 06:15 am EST

Ascendis Pharma A/S Name, Registered Office and Objects of the Company: Article 1 .

United statesDistrict of columbiaMenlo parkNew yorkUnited kingdomPalo altoCayman islandsKingdom of denmarkRepublic of irelandJohnc williamsMarkv roederJoshua hahn ascendis pharmaAscendis pharma adssAscendis pharmasAscendis pharmaBusiness day of the company

vimarsana © 2020. All Rights Reserved.